nach oben

Applied Health Economics and Health Policy

Erschienen in:

01.09.2011 | Erratum

Erratum to: Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis

verfasst von: D. Mueller, A. Gandjour

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Excerpt

Mueller D, Gandjour A. Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis. Appl Health Econ Health Policy 2011; 9 (4): 259–73 …

Titel: Erratum to: Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis
verfasst von: D. Mueller
A. Gandjour
Publikationsdatum: 01.09.2011
Verlag: Springer International Publishing
Erschienen in: Applied Health Economics and Health Policy / Ausgabe 5/2011
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI: https://doi.org/10.2165/11585610-000000000-00000

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2011

Early assessment of medical technologies to inform product development and market access

Assessing quality of life among British older people using the ICEPOP CAPability (ICECAP-O) measure

Nutrition therapy cost analysis in the US

Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE Clinical trial

Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population